BridgeBio Pharma Statistics
Total Valuation
BBIO has a market cap or net worth of $4.79 billion. The enterprise value is $6.08 billion.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
BBIO has 188.03 million shares outstanding. The number of shares has increased by 15.32% in one year.
Shares Outstanding | 188.03M |
Shares Change (YoY) | +15.32% |
Shares Change (QoQ) | +4.97% |
Owned by Insiders (%) | 5.38% |
Owned by Institutions (%) | 66.39% |
Float | 127.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 20.47 |
Forward PS | 15.13 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 27.76 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.59
Current Ratio | 4.59 |
Quick Ratio | 3.34 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -5.78 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -48.44% |
Return on Capital (ROIC) | -60.97% |
Revenue Per Employee | $394,108 |
Profits Per Employee | -$816,221 |
Employee Count | 556 |
Asset Turnover | 0.34 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.15% in the last 52 weeks. The beta is 1.09, so BBIO's price volatility has been similar to the market average.
Beta (5Y) | 1.09 |
52-Week Price Change | -2.15% |
50-Day Moving Average | 25.95 |
200-Day Moving Average | 28.07 |
Relative Strength Index (RSI) | 52.81 |
Average Volume (20 Days) | 1,533,604 |
Short Selling Information
The latest short interest is 17.78 million, so 9.46% of the outstanding shares have been sold short.
Short Interest | 17.78M |
Short Previous Month | 18.63M |
Short % of Shares Out | 9.46% |
Short % of Float | 13.94% |
Short Ratio (days to cover) | 8.60 |
Income Statement
In the last 12 months, BBIO had revenue of $219.12 million and -$453.82 million in losses. Loss per share was -$2.58.
Revenue | 219.12M |
Gross Profit | 216.73M |
Operating Income | -502.99M |
Pretax Income | -453.82M |
Net Income | -453.82M |
EBITDA | -496.59M |
EBIT | -502.99M |
Loss Per Share | -$2.58 |
Full Income Statement Balance Sheet
The company has $447.77 million in cash and $1.73 billion in debt, giving a net cash position of -$1.28 billion or -$6.82 per share.
Cash & Cash Equivalents | 447.77M |
Total Debt | 1.73B |
Net Cash | -1.28B |
Net Cash Per Share | -$6.82 |
Equity (Book Value) | -1.08B |
Book Value Per Share | -5.81 |
Working Capital | 481.87M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$414.88 million and capital expenditures -$1.62 million, giving a free cash flow of -$416.49 million.
Operating Cash Flow | -414.88M |
Capital Expenditures | -1.62M |
Free Cash Flow | -416.49M |
FCF Per Share | -$2.22 |
Full Cash Flow Statement Margins
Gross margin is 98.91%, with operating and profit margins of -229.54% and -207.11%.
Gross Margin | 98.91% |
Operating Margin | -229.54% |
Pretax Margin | -210.62% |
Profit Margin | -207.11% |
EBITDA Margin | -226.63% |
EBIT Margin | -229.54% |
FCF Margin | -190.07% |
Dividends & Yields
BBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.32% |
Shareholder Yield | -15.32% |
Earnings Yield | -9.47% |
FCF Yield | -8.69% |
Dividend Details Analyst Forecast
The average price target for BBIO is $46.83, which is 83.79% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $46.83 |
Price Target Difference | 83.79% |
Analyst Consensus | Strong Buy |
Analyst Count | 13 |
Revenue Growth Forecast (5Y) | 189.20% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BBIO has an Altman Z-Score of -4.13 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.13 |
Piotroski F-Score | 5 |